K KRYSTEXXA PEGLOTICASE Trademark

Trademark Overview

On Friday, November 6, 2020, a trademark application was filed for K KRYSTEXXA PEGLOTICASE with the United States Patent and Trademark Office. The USPTO has given the K KRYSTEXXA PEGLOTICASE trademark a serial number of 90304262. The federal status of this trademark filing is REGISTERED as of Tuesday, December 14, 2021. This trademark is owned by Horizon Therapeutics USA, Inc.. The K KRYSTEXXA PEGLOTICASE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing a website featuring information relating to inflammatory, metabolic and rheumatological disorders and treatment of gout
k krystexxa pegloticase

General Information

Serial Number90304262
Word MarkK KRYSTEXXA PEGLOTICASE
Filing DateFriday, November 6, 2020
Status700 - REGISTERED
Status DateTuesday, December 14, 2021
Registration Number6586611
Registration DateTuesday, December 14, 2021
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements

Description of MarkThe mark consists of the word "KRYSTEXXA" appearing in capital letters, underneath is the word "pegloticase" appearing in lower case letters, and above and to the right of the word "KRYSTEXXA" is a stylized letter "K".
Goods and ServicesProviding a website featuring information relating to inflammatory, metabolic and rheumatological disorders and treatment of gout
NOT AVAILABLE"PEGLOTICASE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 7, 2021
Primary Code044
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History

Party NameHorizon Therapeutics USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDEERFIELD, IL 60015
Party NameHorizon Therapeutics USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045
Party NameHorizon Therapeutics USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLake Forest, IL 60045

Trademark Events

Event DateEvent Description
Tuesday, November 10, 2020NEW APPLICATION ENTERED
Thursday, January 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 31, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 13, 2021ASSIGNED TO EXAMINER
Wednesday, April 21, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 21, 2021NON-FINAL ACTION E-MAILED
Wednesday, April 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021REGISTERED-PRINCIPAL REGISTER
Monday, March 20, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 20, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 19, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

pegloticase krystexxa rheumatological disorders treatment gout metabolic inflammatory website featuring information relating